CMR Surgical

We’re excited to announce that CMR Surgical has been granted U.S. FDA Marketing Authorization for the use of #Versius in Cholecystectomy. The FDA marketing authorization of #Versius is a significant milestone, with Versius being the first multi-port, soft tissue general surgical Robotic Assisted Surgical Device (RASD) to successfully be authorized through FDA’s De Novo application process. Versius is a RASD intended to assist in the precise and accurate control of Versius Surgical endoscopic instruments and is indicated in the U.S. for adult patients 22 years of age and older, eligible for soft tissue minimal access surgery, for cholecystectomy. Read more: https://lnkd.in/eKWPjD4Y #CMRSurgical #TransformingSurgery

We are pleased to share that we have expanded our partnership with Kebomed Sverige AB—one of Europe’s leading distributors of specialist medical devices—to include Sweden, so more patients can benefit from robotic-assisted minimal access surgery with #Versius. The expansion adds to CMR and KEBOMED’s existing partnership which has successfully brought #Versius to Denmark, Norway, and Finland making surgical robotics more widely accessible across the Nordics. Find out more: https://lnkd.in/gXpvbYhM KEBOMED A/S KEBOMED Norge Kebomed Finland #CMRSurgical #TransformingSurgery

Congratulations to Hospital Universitari de Bellvitge in Barcelona, Spain who have completed their first cases using #Versius! The first surgery performed with #Versius at the hospital was a hysterectomy for a fibroid-affected uterus, carried out by Head of the Gynaecology Department at Hospital Universitari de Bellvitge and President of the Spanish Group of Gynaecological Surgery (GERGIN), Dr Jordi Ponce Sebastia and the wider gynaecology team. The versatile and portable design of #Versius will allow the system to be easily moved between the hospital's 33 operating theatres, enabling high utilisation of the system. At Hospital Universitari de Bellvitge, #Versius will initially be used to perform gynaecology and urology surgery before expanding into a wider multispecialty robotic surgery programme. Congratulations again to the entire team at Hospital Universitari de Bellvitge - we look forward to watching your robotic surgery programme continue to flourish with #Versius! #CMRSurgical #TransformingSurgery

We're looking forward to attending the combined RAWS and AWRE conference taking place in London this week with #Versius! We're delighted to be joined by: ALSGBI Association President and Consultant General Surgeon at East Suffolk and North Essex NHS Foundation Trust Professor Tan Arulampalam, and Consultant Colorectal & General Surgeon at Milton Keynes University Hospital NHS Foundation Trust, Adnan Qureshi to present on robotic surgical training, and complex abdominal wall hernia repair with #Versius. We hope to see you there! Book your 1:1 #Versius demo here: https://lnkd.in/eKFepXKM #TransformingSurgery #CMRSurgical AWR Europe

Kickstart the New Year 2025 in Addenbrooke’s Hospital preceptoring talented Endometriosis Surgeon Emily Gelson. CMR Surgical Cambridge University Hospitals NHS Foundation Trust

We're looking ahead to this weekend's Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) NBT Innovation Weekend's Surgical Disruptive Technology Summit, where on Day 2 attendees will have the opportunity to hear from our Chief Medical Officer and Co-founder, Dr Mark Slack. You can catch Mark presenting as part of the 'Finally, A LOT of Robotic Platforms!' session, and taking part in the 'Contrasting Strategic and Startup Viewpoints in Robotic Surgery' panel discussion. We look forward to seeing you there! #TransformingSurgery

"You're giving [surgeons] back an instrument that they're used to using laparoscopically and therefore you give them the familiarity, and with that, comes confidence." Our Chief Medical Officer and Co-Founder, Dr Mark Slack shares how the Ultrasonic Dissector—our first advanced energy instrument providing surgeons with a new option for haemostatic coagulation and simultaneous cutting—can support surgeons through more complex surgical procedures with #Versius. Find out more about the Ultrasonic Dissector: https://lnkd.in/eu4PMaXS #CMRSurgical #TransformingSurgery

We're looking forward to a jam-packed weekend ahead at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) NBT Innovation Weekend's Surgical Disruptive Technology Summit! We are delighted to have our Chief Medical Officer and Co-founder, Mark Slack, and Michelle Paknad, President of Global Marketing & US Market Entry, attending in-person to represent CMR Surgical. Mark will be covering all things #Versius on day 2; presenting as part of the 'Finally, A LOT of Robotic Platforms!' session, and taking part in the 'Contrasting Strategic and Startup Viewpoints in Robotic Surgery' panel discussion. We hope to see you there! #TransformingSurgery

Rufus Quinn, aged 7, has become the first child in London to successfully undergo an operation using a new Versius robotic system at Evelina London. The Versius system contains four flexible arms designed to mimic human joints. During an operation, a surgeon controls these arms on a console. Any movements made by the surgeon are translated into smaller, more precise motions in the robot’s arms. Although Versius is regularly used for adult surgeries, Rufus’ operation was part of a new clinical trial to test the use of this robotic system on children. It is hoped Versius will speed up patient recovery times and make complex operations less tiring for surgeons. #TeamGSTT #RoboticSurgery #EvelinaLondon

We're excited to be featured in the top 20 of the inaugural The Sunday Times 100 Tech, ranking Britain’s fastest-growing tech firms. 2024 was a year of exciting firsts for CMR: From the launch of our integrated ICG viewing platform #vLimeLite, and our first advanced-energy instrument in the #UltrasonicDissector as part of our #VersiusPlus offering; to securing US FDA Marketing approval for the use of #Versius in Cholecystectomy; and the start of the world’s first multicentre prospective clinical trial on the use of #Versius in paediatric surgery all whilst remaining steadfast in our mission to make robotic assisted minimal access surgery accessible to patients around the world with #Versius, so we're incredibly proud to be recognised in this way. Thank you to The Times for honouring us alongside such an incredible cohort of innovators and changemakers from across the UK. Find out more and see the full #sundaytimes100 list here: https://lnkd.in/eutHt7Je #TransformingSurgery